Dados B3 › OPGM3 × OSXB3

OPGM3 × OSXB3

OPGM3

GAMA PARTICIPAÇÕES S.A.
Holdings/Diversificado

4 restated figures

OSXB3

OSX BRASIL S.A. - EM RECUPERAÇÃO JUDICIAL
Holdings/Diversificado

62 restated figures

Indicators

Each row uses the most recent year in which BOTH companies have the figure, and says which year that is. A cell with ^! carries a caveat — hover to read it. We do not name a winner: that would be a recommendation, and this site does not give any.

indicator	OPGM3	OSXB3	year
ROE	23.6%^!	-1,347.5%	2014
ROIC	-999.9%^!	-47.5%^!	2018
ROA	-2.4%^!	-106.3%^!	2025
Gross margin	—	100.0%^!	no year where both have it
EBIT margin	—	-294.4%^!	no year where both have it
Net margin	—	-1,339.1%^!	no year where both have it
Net debt/EBITDA	—	9.36x	no year where both have it
Current ratio	985.00x^!	0.04x^!	2025
Revenue growth (1y)	—	28.3%^!	no year where both have it
Revenue growth (5y CAGR)	—	49.5%^!	no year where both have it
Piotroski F-Score	2/9^!	5/9^!	2025

Point-in-time multiples

Priced at the first session on or after the day each filing became public — never the period close.

indicator	OPGM3	OSXB3	year
P/E	—	-0.00x	None × 2025
P/B	—	—	None × 2025
EV/EBITDA	—	—	None × 2025
FCF yield	—	128.9%	None × 2025

OPGM3 · OSXB3 · filter the whole market · methodology

Numbers on this page are live. Data version 2026-09-01-supressao-declarada · page generated 2026-09-09 13:40 UTC. If this does not match /saude, you are reading a cached copy.

Sources: CVM (open data, ODbL) and B3 (COTAHIST). Not affiliated with B3 or the CVM. Not investment advice.